Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, China.
Scand J Immunol. 2012 Dec;76(6):521-7. doi: 10.1111/j.1365-3083.2012.02765.x.
Granulocyte-monocyte colony-stimulating factor (GM-CSF) regulates the function of antigen-presenting cells (APCs) and has been broadly used as the adjuvant. Here, we tested whether intranasal delivery of GM-CSF can improve the contraception of mouse zona pellucida 3 (mZP3) DNA vaccine. Our results showed that co-administration of GM-CSF and mZP3 DNA vaccine increased the levels of secretory IgA (sIgA) and IgG antibodies in vaginal washes and serum, respectively. Co-administration enhanced Th2 responses through improving the maturation of dendritic cells. Importantly, GM-CSF significantly reduced the fertility rate and mean litter size induced by mZP3 DNA vaccine alone without interfering the normal follicular development. These data suggest that GM-CSF could be used as adjuvant to develop immunocontraceptive vaccine.
粒细胞-巨噬细胞集落刺激因子(GM-CSF)调节抗原提呈细胞(APC)的功能,已被广泛用作佐剂。在这里,我们测试了 GM-CSF 的鼻腔内给药是否可以改善透明带 3(mZP3)DNA 疫苗的避孕效果。我们的结果表明,GM-CSF 与 mZP3 DNA 疫苗联合给药分别增加了阴道冲洗液和血清中分泌型 IgA(sIgA)和 IgG 抗体的水平。联合给药通过改善树突状细胞的成熟来增强 Th2 反应。重要的是,GM-CSF 可显著降低 mZP3 DNA 疫苗单独诱导的生育力和平均窝仔数,而不干扰正常的卵泡发育。这些数据表明,GM-CSF 可用作佐剂来开发免疫避孕疫苗。